ÂÜÀòÂÒÂ×

Simon Douglas is an experienced leader in the biotechnology and diagnostic sectors, currently serving as Non Executive Chairman at Abselion and Fusion Antibodies plc, alongside roles as Chief Executive at C Major Medical and Non Executive Chairman at Cambridge Nutritional Sciences plc. With a background that includes pivotal positions such as Chief Executive at Biofortuna and Executive Chairman at Lab 901, Simon has a rich history in developing innovative laboratory instruments and healthcare solutions. Educational credentials include a PhD in Antibody Imaging of Tumours and a BSc in Chemistry, both from the University of Southampton.